Skip to content

Depression: all studies

Page 906 of 1,036: studies 9,051 to 9,060 of 10,358, newest first. Back to the depression overview

Research

The effects and toxicity of cathinones from the users' perspectives: A qualitative study.

Human Psychopharmacology: Clinical and Experimental May 1, 2017 Sulaf Assi, Nargilya Gulyamova, Paul Kneller et al. 35 citations

The objective of this study is to explore the users' perspectives regarding the effects and toxicity of cathinones. A systematic search of Internet discussion forums yielded 303 threads relevant to the research objectives. The threads were analysed by conventional content analysis where concepts were developed from codes and themes. The study identified 3 main themes in relation to cathinone...

DOI: 10.1002/hup.2610 (opens in new tab) Full text (opens in new tab) Cathinones Content analysis Effects Novel psychoactive substances +2

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.

Phytochemistry May 1, 2017 André R. Cruz, Sara Domingos, Eugenia Gallardo et al. 44 citations

Until the mid-60s, only the Mazatecs, an indigenous group from Oaxaca, Mexico, used Salvia Divinorum (S. divinorum) due to its hallucinogen properties. Later it was found that the hallucinogen effects of this plant were caused by the presence of a neoclerodane diterpene Salvinorin A (salvinorin A), which is a highly selective agonist of kappa-opioid receptor (KOR) that cause more intense...

1255 An Unusual Clinical Presentation of a Parasomnia

Sleep April 28, 2017 Musawer Iqbal, Alireza Yarahmadi, F. Ashraf et al. 1 citation

Parasomnias are defined as undesirable physical events or experiences that occur during entry to sleep, within sleep, or during arousals from sleep. The non REM (NREM) parasomnias include confusional arousals, sleepwalking, and sleep terrors. In children, NREM parasomnias occur out of stage N3 (first part of the night) but in adults can occur out of stages N1 or N2 during any part of the night....

1075 VERBAL MEMORY FUNCTIONING MODERATES RESPONSE TO TREATMENT FOR RECURRENT NIGHTMARES IN PTSD

Sleep April 28, 2017 JC Scott, GC Harb, JA Brownlow et al.

Imagery rehearsal therapy (IR) is arguably the most effective form of cognitive-behavioral therapy (CBT) for the prominent nightmare disturbance in PTSD. CBT for insomnia (CBT-I) may also have efficacy for treating this problem. Although PTSD is associated with cognitive deficits in attention, executive control, and retrospective memory, functions likely essential to CBT outcome, no study has...

0730 EFFECT OF EVERYDAY ANXIETY AND PSYCHOLOGICAL WELL-BEING ON THE RECALL OF DISTURBED DREAMING

Sleep April 28, 2017 Cristina Banu, Pierre McDuff, Antonio Zadra 1 citation

The present study tested a prediction from Levin and Nielsen’s (2007) neurocognitive model of disturbed dreaming stipulating that variations in the frequency of bad dreams and nightmares are partly determined by day-to-day variations in emotional stress. The model also suggests that relations between dreams and stress may vary as a function of personality traits. 224 adults (186F, 38M, mean...

ПСИХОТИЧЕСКИЕ РАССТРОЙСТВА У ЛИЦ, УПОТРЕБЛЯЮЩИХ СИНТЕТИЧЕСКИЕ КАННАБИНОИДЫ (СПАЙСЫ)

April 28, 2017 Иванова Людмила Александровна, Терских Татьяна Владимировна, Тарасенко Татьяна Владимировна et al.

The study involved the group of patients (n = 40) with psychotic disorders who used synthetic cannabinoids (spice). Among the psychotic disorders according to ICD-10 we allocated intoxication delirium (F12.03; 35 %), schizophreniform disorder (F12.50; 60 %), disorder with predominantly manic psychotic symptoms (F12.55; 5 %). The average age of patients was 25.2 ± 4.4 years. Hereditary...

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Scientific Reports April 27, 2017 Isaac Cohen, Tigran Makunts, Rabia Samady Atayee et al. 27 citations

Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Adverse Effect Reporting System. The results of the examination of population scale data revealed that patients...

A Pilot Study of Mindfulness Meditation for Pediatric Chronic Pain

Children April 26, 2017 Lynn C Waelde, Amanda Feinstein, Rashmi Bhandari et al.

Despite advances in psychological interventions for pediatric chronic pain, there has been little research examining mindfulness meditation for these conditions. This study presents data from a pilot clinical trial of a six-week manualized mindfulness meditation intervention offered to 20 adolescents aged 13–17 years. Measures of pain intensity, functional disability, depression and parent...

Meditation awareness training for the treatment of workaholism: A controlled trial

Journal of Behavioral Addictions April 19, 2017 William van Gordon, Edo Shonin, Thomas J. Dunn et al. 144 citations

Background and aims Workaholism is a form of behavioral addiction that can lead to reduced life and job satisfaction, anxiety, depression, burnout, work-family conflict, and impaired productivity. Given the number of people affected, there is a need for more targeted workaholism treatments. Findings from previous case studies successfully utilizing second-generation mindfulness-based...

Should addiction researchers be interested in psychedelic science?

Drug and Alcohol Review April 10, 2017 Stephen Bright, M.l. Williams, David Caldicott 5 citations

As recently noted by Strauss, Bright and Williams 1, while much of the Western world has been experiencing a renaissance in research into ‘psychedelic science’ over the past decade 2, there has been no such research conducted in Australia. In Europe and the USA, studies have been conducted into lysergic acid diethylamide (LSD) that have improved our understanding of brain function 3 and reduced...